Search hospitals > Minnesota > Virginia
Essentia Health Virginia Clinic
Claim this profileVirginia, Minnesota 55792
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
121 reported clinical trials
2 medical researchers
Summary
Essentia Health Virginia Clinic is a medical facility located in Virginia, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Essentia Health Virginia Clinic is involved with conducting 121 clinical trials across 298 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Bret E. FridayEssentia Health Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
109 reported clinical trials
180 drugs studied
Bret EB FridayEssentia Health - Deer River Clinic5 years of reported clinical research
Studies Glioblastoma
Studies Cognitive Impairment
2 reported clinical trials
1 drug studied
Clinical Trials running at Essentia Health Virginia Clinic
Breast Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Bladder Cancer
Diffuse Large B-Cell Lymphoma
Rectal Cancer
Tumors
Cutaneous Melanoma
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Essentia Health Virginia Clinic?
Essentia Health Virginia Clinic is a medical facility located in Virginia, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Essentia Health Virginia Clinic is involved with conducting 121 clinical trials across 298 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.